flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Semaglutides Are Poised to Remake Chronic Disease Care Effects of Semaglutide on Heart

The GLP-1 pathway is probably the most familiar to those who have followed the weight loss medication landscape

Cyanocob 250 Injection is a veterinary Cyanocobalamin (Vitamin B12) formulation designed to support metabolic activity, blood formation and overall animal vitality

Wegovy, Ozempic, Mounjaro, and Zepbound are FDA-approved brand-name products made by Novo Nordisk (semaglutide) and Eli Lilly (tirzepatide)

While these large-scale observational studies are encouraging, more research is needed, including randomized controlled trials to determine whether GLP-1 medications directly reduce substance use, including stimulant use, and improve long-term recovery outcomes

doi: 10.2337/db14-0302 37 BurmeisterMAAyalaJDruckerDJAyalaJE

Science 296 (5571), 13131316